Artificial Intelligence (AI) is revolutionizing the health care industry with its transformative potential to enhance patient care, boost medical professional satisfaction, and accelerate research in medical device development and drug discovery. AI can also drive operational efficiency by enabling personalized treatments and streamlining healthcare processes.
The FDA recognizes the importance of appropriately integrating AI into the healthcare ecosystem to harness its benefits while mitigating risks and challenges. Efforts are underway across various medical product centers, as detailed in the paper “Artificial Intelligence & Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” to support the development and use of AI.
The Digital Health Center of Excellence (DHCoE) aims to promote responsible AI innovations in healthcare, ensuring these technologies are safe and effective when used as medical devices. The DHCoE also seeks to foster collaboration and alignment within the healthcare ecosystem to optimize the integration of AI in health care.1
You may read the full text here.
References
- Center for Devices and Radiological Health. (2024, June 17). BLOG: The promise artificial intelligence holds for improving health care. U.S. Food And Drug Administration. https://www.fda.gov/medical-devices/digital-health-center-excellence/blog-promise-artificial-intelligence-holds-improving-health-care
Disclaimers
- The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
